Ron Finklestien
Rodman & Renshaw Launches Coverage of Adial Pharmaceuticals (ADIL) with Strong Buy Rating
Rodman & Renshaw Launches Coverage of Adial Pharmaceuticals with High Growth Potential Analysts Anticipate 577% Growth for Adial Pharmaceuticals Fintel reported on November 14, ...
Why You Should Consider This Exceptional Biotech Stock Over Eli Lilly
Can Viking Therapeutics Compete with Eli Lilly’s Weight Loss Giants? Eli Lilly (NYSE: LLY) has been making headlines lately with its impressive earnings, largely ...
DallasNews Reports Wider Q3 Loss Year-over-Year, but Shares Rise 5%
DallasNews Corporation Reports Larger Loss, Stock Rises Amid Market Changes Shares of DallasNews Corporation (DALN) rose by 4.8% following the release of its earnings ...
AMD Streamlines Workforce to Prioritize AI Chip Development
AMD Cuts Workforce to Boost AI Chip Development Advanced Micro Devices (AMD) will lay off approximately 4% of its global workforce, equating to around ...
UBS Starts Coverage on EPR Properties Preferred Stock (EPR.PRC) with Neutral Outlook
UBS Starts Coverage on EPR Properties – Preferred Stock with Neutral Outlook On November 14, 2024, UBS began its coverage of EPR Properties – ...
Meta Announces New Ad Features for Threads Amid Ongoing Antitrust Trial for Instagram and WhatsApp
Meta Platforms Makes Waves with New Ads on Threads and Antitrust Trial Meta Platforms (META) is in the spotlight with significant updates on multiple ...
Why an Increase in Social Security Taxes in 2025 Might Not Be a Cause for Concern
Upcoming Changes to Social Security in 2025: What You Need to Know Starting in January, Social Security beneficiaries will see a 2.5% cost-of-living adjustment ...
